| editorial | Q871232 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/ART.40063 |
| P698 | PubMed publication ID | 28382651 |
| P50 | author | Jean-Pierre Raynauld | Q90067190 |
| P2093 | author name string | Jean-Luc Senécal | |
| Yves Troyanov | |||
| P2860 | cites work | Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes | Q33293736 |
| Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ. | Q33814323 | ||
| Polymyositis and dermatomyositis (first of two parts) | Q33911013 | ||
| Polymyositis: an overdiagnosed entity | Q34536136 | ||
| Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial | Q34644962 | ||
| Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome. | Q34661961 | ||
| The autoantibody repertoire: searching for order | Q35038302 | ||
| Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy | Q35638565 | ||
| An autoimmune myositis-overlap syndrome associated with autoantibodies to nuclear pore complexes: description and long-term follow-up of the anti-Nup syndrome | Q36150817 | ||
| Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features | Q36150826 | ||
| Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients | Q36190260 | ||
| Clinical Spectrum Time Course in Anti Jo-1 Positive Antisynthetase Syndrome: Results From an International Retrospective Multicenter Study. | Q36195131 | ||
| Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis | Q36893955 | ||
| Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum. | Q36947409 | ||
| Number, characteristics, and classification of patients with dermatomyositis seen by dermatology and rheumatology departments at a large tertiary medical center | Q36965164 | ||
| Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis | Q37704799 | ||
| Correlation of clinicoserologic and pathologic classifications of inflammatory myopathies: study of 178 cases and guidelines for diagnosis | Q37726608 | ||
| Acquired immune and inflammatory myopathies: pathologic classification | Q37936148 | ||
| A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy. | Q38596370 | ||
| The Clinical Features of Myositis-Associated Autoantibodies: a Review | Q38603422 | ||
| Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management | Q38619882 | ||
| Statin-Associated Autoimmune Myopathy | Q38737361 | ||
| Autoantigens as Partners in Initiation and Propagation of Autoimmune Rheumatic Diseases. | Q38747090 | ||
| High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody. | Q40795767 | ||
| 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatri | Q46815762 | ||
| American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis | Q47643186 | ||
| Autoantibody levels in myositis patients correlate with clinical response during B cell depletion with rituximab. | Q52861037 | ||
| Nuclear actin aggregation is a hallmark of anti-synthetase syndrome-induced dysimmune myopathy. | Q52868984 | ||
| Inflammatory Muscle Diseases | Q55953708 | ||
| 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10–12 October 2003, Naarden, The Netherlands | Q57752724 | ||
| Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic scl | Q58160729 | ||
| A novel autoantibody to a 155-kd protein is associated with dermatomyositis | Q58490778 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 878-884 | |
| P577 | publication date | 2017-04-06 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | Editorial: A New Classification of Adult Autoimmune Myositis. | |
| P478 | volume | 69 |
| Q48285249 | Anti-aminoacyl-tRNA synthetase-related myositis and dermatomyositis: clues for differential diagnosis on muscle biopsy. |
| Q91059371 | Classification and management of adult inflammatory myopathies |
| Q54977148 | Current Classification and Management of Inflammatory Myopathies. |
| Q47235167 | Describing and expanding the clinical phenotype of anti-MDA5-associated rapidly progressive interstitial lung disease: case series of nine Canadian patients and literature review |
| Q52628910 | Immune-Mediated Necrotizing Myopathy. |
| Q55277507 | New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter. |
| Q41111946 | RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis |
| Q57814497 | Seronegative patients form a distinctive subgroup of immune-mediated necrotizing myopathy |
| Q92155590 | Statin-Associated Necrotizing Autoimmune Myositis Complicated by an Uncommon Adverse Effect to Treatment |
| Q92501690 | Statin-induced anti-HMGCR myopathy: successful therapeutic strategies for corticosteroid-free remission in 55 patients |
| Q64275961 | The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients |
| Q59798184 | The Utilization of Autoantibodies in Approaches to Precision Health |
Search more.